Essential Psychopharmacology: the Prescriber's Guide: AntidepressantsIn response to the rapid developments in psychopharmacology, this is a spin-off from Stephen Stahl's new, completely revised and updated edition of his much acclaimed Prescriber's Guide. This is a pragmatic, easy-to-use formulary for prescribing clinicians, covering the most important drugs in use today for depression. From a review of the first Prescriber's Guide: ' ... The clinical tips and pearls that are found in each entry are invaluable - not only are dosing guidelines provided, but also the author's educated and respected opinion regarding potential advantages and disadvantages of each drug. The book's major strength is its readability and user friendliness. The art of psychopharmacology is finally given the space it deserves. 0133 This guidebook is an excellent source of information for the art of prescribing psychotropic medications and belongs in every clinician's library.' The Annals of Pharmacotherapy |
Contents
amitriptyline | 1 |
amoxapine | 9 |
atomoxetine | 17 |
bupropion | 23 |
citalopram | 29 |
clomipramine | 35 |
desipramine | 43 |
dothiepin | 51 |
milnacipran | 113 |
mirtazapine | 119 |
moclobemide | 125 |
nefazodone | 131 |
nortriptyline | 137 |
paroxetine | 145 |
phenelzine | 153 |
protriptyline | 159 |
doxepin | 57 |
duloxetine | 65 |
escitalopram | 71 |
fluoxetine | 77 |
fluvoxamine | 83 |
imipramine | 89 |
isocarboxazid | 95 |
lofepramine | 101 |
maprotiline | 107 |
reboxetine | 165 |
selegiline | 171 |
sertraline | 179 |
tianeptine | 185 |
tranylcypromine | 189 |
trazodone | 195 |
trimipramine | 201 |
venlafaxine | 207 |
Other editions - View all
Common terms and phrases
actions activation addition agent agitation amphotericin and/or anxiety anxiety disorders arrhythmias augmenting agent avoid Best bipolar disorder Blocks breast feeding bupropion cardiac carefully cause caution child children and adolescents chronic clomipramine combinations concentrations condition Consider continuing treatment depression discontinuation disease dopamine Dosage dose drug efficacy episodes especially evaluation experience first give glucose half-life heart hypotension immediate Impairment improved increase inhibit initial insomnia interactions lack levels lower MAO inhibitors MAOIs mg/day moclobemide Monitor mood stabilizer mother myocardial infarction observe once pain paroxetine patient is taking patients period plasma populations possibility Potential pregnancy prevent QTc interval Rare receptors recommended reduce relapse reported require response reuptake inhibitor risks and benefits sedation seizures selected serotonin serotonin reuptake severe side effects sometimes SSRIs stopped studies suicidal ideation switching symptoms taking TCAs therapeutic tolerate trazodone treating treatment-resistant tricyclic tricyclic/tetracyclic antidepressants trimester usually Wait weeks weigh the risks weight gain withdrawal